EAN 2026: MS Copilot shows promise in monitoring disability progression in MS
Sanofi/Ad Scientiam presented an interim analysis from the ongoing MS-DETECT (NCT05816122) study, showing that Microsoft (MS) Copilot can monitor disease…
Analyst Comment
Penumbra’s Thunderbolt approval poised to accelerate neuro thrombectomy innovation
Medtronic’s Evolut displays superior clinical outcomes
Latest foreign investment in UK highlights underserved potential of primary care technology
ACC 2026: Post-TAVR treatments show potential in reducing cardiovascular risks
Epic secures a £222m federated EPR contract across Somerset and Dorset
Knight Therapeutics advances chronic GvHD expansion strategy
JPM26: Ypsomed commits to self-care delivery devices in new strategic plan
